What is it about?
DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior such as LNM and ETE in papillary thyroid cancer
Featured Image
Why is it important?
An important biomarker for prediction of aggressiveness of PTC
Read the Original
This page is a summary of: DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of papillary thyroid cancer, OncoTargets and Therapy, April 2016, Dove Medical Press,
DOI: 10.2147/ott.s103554.
You can read the full text:
Contributors
The following have contributed to this page
